Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial

References

• VarmaghaniM, DehghaniM, HeidariE, et al. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47–57. doi:10.26719/emhj.18.01430919925
   PubMed Web of Science ®Google Scholar
• LozanoR, NaghaviM, ForemanK, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-023245604
   PubMed Web of Science ®Google Scholar
• WangC, XuJ, YangL, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-929650248
   PubMed Web of Science ®Google Scholar
• EisnerMD, AnthonisenN, CoultasD, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718. doi:10.1164/rccm.200811-1757ST20802169
   PubMed Web of Science ®Google Scholar
• BarnesPJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. doi:10.1016/j.jaci.2016.05.01127373322
   PubMed Web of Science ®Google Scholar
• MacNeeW. ABC of chronic obstructive pulmonary disease: pathology, pathogenesis, and pathophysiology. BMJ. 2006;332(7551):1202–1204. doi:10.1136/bmj.332.7551.1202
   Web of Science ®Google Scholar
• WedzichaJA, SeemungalTA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-817765528
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2019 Available from: https://goldcopd.org. Accessed 310, 2020.
   Google Scholar
• LiaoYN, HuWL, ChenHJ, et al. the use of chinese herbal medicine in the treatment of chronic obstructive pulmonary disease (COPD). Am J Chin Med. 2017;45(2):225–238. doi:10.1142/S0192415X1750014828231744
   PubMed Web of Science ®Google Scholar
• GeorgeJ, Ioannides-DemosLL, SantamariaNM, et al. Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Med J Aust. 2004;181:248–251. doi:10.5694/j.1326-5377.2004.tb06262.x15347271
   PubMed Web of Science ®Google Scholar
• LiSY, LiJS, WangMH, et al. Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study. BMC Complement Altern Med. 2012;12:197. doi:10.1186/1472-6882-12-19723107470
   PubMed Web of Science ®Google Scholar
• WangG, LiuB, CaoY, et al. Effects of two Chinese herbal formulae for the treatment of moderate to severe stable chronic obstructive pulmonary disease: a multicenter, double-blind, randomized controlled trial. PLoS One. 2014;9(8):e103168. doi:10.1371/journal.pone.010316825118962
   PubMed Web of Science ®Google Scholar
• AnX, ZhangAL, YangAW, et al. Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review. Respir Med. 2011;105:165–176. doi:10.1016/j.rmed.2010.11.00721146973
   PubMed Web of Science ®Google Scholar
• ShergisJ, DiYM, ZhangAL, et al. Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease. Complement Ther Med. 2014;22:944–953. doi:10.1016/j.ctim.2014.08.00625440386
   PubMed Web of Science ®Google Scholar
• ShergisJL, ZhangAL, ZhouW, et al. Panax ginseng in randomised controlled trials: a systematic review. Phytother Res. 2013;27:949–965. doi:10.1002/ptr.v27.722969004
   PubMed Web of Science ®Google Scholar
• CoonJT, ErnstE. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 2002;25:323–344. doi:10.2165/00002018-200225050-0000312020172
   PubMed Web of Science ®Google Scholar
• WuL, ZhangAL, DiYM, et al. Panax ginseng therapy for chronic obstructive pulmonary disease: a clinical trial protocol and pilot study. Chin Med. 2014;9:20. doi:10.1186/1749-8546-9-2025161696
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease; 2012.
   Google Scholar
• ScaglioneF, PannacciM, PetriniO. The standardised G115 Panax ginseng C.A. Meyer extract: a review of its properties and usage. Evid Based Integr Med. 2005;2(4):195–206. doi:10.2165/01197065-200502040-00003
   Google Scholar
• AnthonisenNR, ManfredaJ, WarrenCP, HershfieldES, HardingGK, NelsonNA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-1963492164
   PubMed Web of Science ®Google Scholar
• ZhengJP, KangJ, HuangSG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet. 2008;371(9629):2013–2018. doi:10.1016/S0140-6736(08)60869-718555912
   PubMed Web of Science ®Google Scholar
• ShergisJL, ThienF, WorsnopCJ, et al. 12-month randomised controlled trial of ginseng extract for moderate COPD. Thorax. 2019;74(6):1–7. doi:10.1136/thoraxjnl-2018-212665
   Web of Science ®Google Scholar
• BianLQ, LiBS, LiZH, et al. A preparation model of Chinese medicine decoction placebo. Chin J Integr Med. 2017;23(8):631–634. doi:10.1007/s11655-016-2538-628035537
   PubMed Web of Science ®Google Scholar
• HuangQH, XiaoJ, SunYM, et al. Preparation and quality evaluation of traditional Chinese medicine compound placebo. Chin Med. 2015;56(15):1294–1297.
   Google Scholar
• MaJ, ZhengJ, ZhongN, et al. Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study. Int J Chron Obstruct Pulmon Dis. 2018;13:3107–3114. doi:10.2147/COPD30323581
   PubMed Web of Science ®Google Scholar
• ZhengJP, WenFQ, BaiCX, et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2014;2(3):187–194. doi:10.1016/S2213-2600(13)70286-824621680
   PubMed Web of Science ®Google Scholar
• TashkinDP, CelliB, SennS, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554. doi:10.1056/NEJMoa080580018836213
   PubMed Web of Science ®Google Scholar